London, UK – 22nd May 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with AIM Rules 20 and 26, the Group’s Annual Report and Accounts for the year ended 31 December 2017 and Notice of Annual General Meeting have been sent to shareholders today and are available on the Company’s website in the Investor Relations section at http://www.netscientific.net/investors.
The Annual General Meeting of the Group will be held on Thursday, 21 June 2018 at 11.00 a.m. at Ashurst LLP, Broadwalk House, 5 Appold Street, London EC2A 2AG, United Kingdom.
# # #
For more information, please contact:
| NetScientific
François R. Martelet, M.D., CEO Ian Postlethwaite, CFO |
Tel: +44 (0)20 3514 1800 |
|
Consilium Strategic Communications Mary-Jane Elliott / Jessica Hodgson / Chris Welsh / Laura Thornton |
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
| Stifel Nicolaus Europe Limited (NOMAD and Broker)
Jonathan Senior / David Arch / Ben Maddison |
Tel: +44 (0) 20 7710 7600
|
About NetScientific
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
